Impact of PSA nadir on long-term survival in metastatic hormone-sensitive prostate cancer: Final 10-year analysis of the ECOG-ACRIN E3805 CHAARTED trial.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Abhishek Tripathi, Yu-Hui Chen, David Frazier Jarrard, Jorge A. Garcia, Robert Dreicer, Glenn Liu, Maha H. A. Hussain, Daniel Shevrin, Matthew M. Cooney, Mario A. Eisenberger, Manish Kohli, Elizabeth R. Plimack, Nicholas J. Vogelzang, Joel Picus, Michael A Carducci, Robert S. DiPaola, Christopher Sweeney
Institutions: City Of Hope National Medical Center, Dana-Farber Cancer Institute, University of Wisconsin–Madison, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, University of Virginia, University of Wisconsin Carbone Cancer Center, Northwestern University, Endeavor Health, Tempus Labs (United States), Johns Hopkins University, Huntsman Cancer Institute, Fox Chase Cancer Center, Comprehensive Cancer Centers of Nevada, Washington University in St. Louis, University of Kentucky
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407701193